Gibson, Dunn & Crutcher LLP advised GE Healthcare Technologies Inc. on the pricing of the secondary underwritten public offering. GE HealthCare Technologies Inc. (Nasdaq: GEHC) priced the...
GE HealthCare Technologies Inc.’s Secondary Offering
General Electric’s $1.95 Billion Debt-for-Equity Exchange
Gibson Dunn advised GE HealthCare Technologies, Paul, Weiss advised General Electric, and Simpson Thacher advised the representatives of the underwriters. Simpson Thacher also represented Morgan Stanley...
GE Healthcare’s Joint Venture and Follow-up Business Cooperation with CMDC
JunHe advised GE Healthcare on the deal. GE Healthcare (China) Co., Ltd. and China National Medical Device Co., Ltd. signed agreements to establish a medical equipment joint...
GE HealthCare’s Acquisition of IMACTIS
Hogan Lovells advised IMACTIS. Shearman & Sterling LLP advised GE HealthCare. GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire IMACTIS,...
GE Healthcare Holding’s $8.25 Billion Bond Offering
Cleary Gottlieb represented the initial purchasers in the offering, while Paul, Weiss advised GE HealthCare. GE Healthcare Holding LLC (GE HealthCare), a subsidiary of General Electric...
GE Healthcare’s Acquisition of Zionexa
Stephenson Harwood, De Marcellus and Disser, Mercure Avocats, Troutman Pepper advised GE Healthcare on the transaction while Goodwin Procter LLP advised the shareholders of Zionexa. Zionexa,...